AGP Executive Report
Last update: 4 hours agoEU Health Approvals: Merck’s KEYTRUDA plus Padcev has cleared a positive EU CHMP opinion for cisplatin-ineligible adults with resectable muscle-invasive bladder cancer, with an EU decision expected in Q3 2026—while Pharming’s Joenja (leniolisib) has also won EU marketing authorization as the first approved treatment for APDS, targeting adults and kids 12+ (first launch expected in Germany in Q3 2026). Diplomacy & Trade: Modi’s Nordic push is back in the spotlight after Oslo talks upgraded India–Norway ties to a “Green Strategic Partnership,” with clean energy, blue economy and green shipping on the agenda. Liechtenstein in the mix: Liechtenstein is explicitly included in the EU review path for the KEYTRUDA regimen, and it also appears in the wider regional finance conversation around stability. Culture & Art: Uruguay donated a major sculpture to the ICC in The Hague, turning international justice into a public art moment. Travel Rules: Thailand is rolling visa-free stays back to 30 days for most nationalities, tightening entry after overstays and security concerns. Human Interest: A fundraiser completed a solo Vespa ride through Liechtenstein and beyond to support mental health and suicide prevention.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
